sodium salicylate has been researched along with Benign Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Blagih, J; Coelho, PP; Griss, T; Jones, RG; Vincent, EE; Viollet, B | 1 |
| Iwakoshi, C; Karasawa, K; Ogino, Y; Ohki, M; Yamaguchi, A | 1 |
| Bae, YS; Chung, YM; Lee, SY | 1 |
| FRIEDELL, GH; SHERMAN, JD | 1 |
| Becker, PD; Camacho, EM; Cebolla, A; Guzmán, CA; Link, C; Royo, JL; Santero, E | 1 |
| Finlay, BB; Gal-Mor, O | 1 |
1 review(s) available for sodium salicylate and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
6 other study(ies) available for sodium salicylate and Benign Neoplasms
| Article | Year |
|---|---|
Differential effects of AMPK agonists on cell growth and metabolism.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Animals; Biphenyl Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Glucose; HCT116 Cells; HEK293 Cells; Humans; Hypoglycemic Agents; Lactic Acid; Metformin; Mice; Neoplasms; Phenformin; Pyrones; Ribonucleotides; Sodium Salicylate; Thiophenes | 2015 |
[Trigger point therapy for myofascial pain in cancer patients (second report) analysis results of special use-results surveillance by neovitacain® injection].
Topics: Dibucaine; Humans; Injections; Myofascial Pain Syndromes; Neoplasms; Pyridoxine; Sodium Salicylate; Surveys and Questionnaires; Trigger Points | 2012 |
Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-X Protein; Caspase 3; Caspase 9; Caspases; Colonic Neoplasms; Cytochrome c Group; Enzyme Activation; Gene Expression; Humans; Membrane Potentials; Mitochondria; NADPH Oxidases; Neoplasms; Proto-Oncogene Proteins c-bcl-2; rac1 GTP-Binding Protein; Reactive Oxygen Species; Sodium Salicylate; Stomach Neoplasms; Transfection; Tumor Cells, Cultured | 2003 |
The treatment of anemia in the tumor-bearing hamster with cortisone and sodium salicylate.
Topics: Anemia; Anemia, Hemolytic; Animals; Antineoplastic Agents; Cortisone; Cricetinae; Fibrosarcoma; Neoplasms; Neoplasms, Experimental; Salicylates; Sodium Salicylate | 1963 |
In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit.
Topics: 3-Phosphoshikimate 1-Carboxyvinyltransferase; Animals; Aspirin; Bacterial Proteins; beta-Galactosidase; Cell Line, Tumor; Flucytosine; Fluorouracil; Gene Expression; Gene Expression Regulation, Bacterial; Genetic Engineering; Green Fluorescent Proteins; HeLa Cells; Humans; Lac Operon; Macrophages; Mice; Neoplasms; Operon; Promoter Regions, Genetic; Salmonella enterica; Salmonella Infections; Sodium Salicylate; Spleen; Transcription Factors | 2007 |
Pathogens on aspirin: promising research and therapeutic applications.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Proteins; Flucytosine; Fluorouracil; Gene Expression Regulation, Bacterial; Mice; Neoplasms; Salmonella enterica; Salmonella Infections; Sodium Salicylate | 2007 |